Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Paris saponin VII
Cat. No.:
OB0225LY-0489
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Paris saponin VII is an important compound with the ability to inhibit cell proliferation.
Synonym:
Chonglou saponin VII; Paris saponin-VII; 68124-04-9; Pennogenin tetraglycoside; Paris VII; beta-D-Glucopyranoside, (3beta,25R)-17-hydroxyspirost-5-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(O-6-deoxy-alpha-L-mannopyranosyl-(1-4)-6-deoxy-alpha-L-mannopyranosyl-(1-4))-
CAS No.:
68124-04-9
Compound CID:
176233
Formula:
C51H82O21
Formula Weight:
1031.18
Specification
Relative Density:
1.45 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Paris saponin VII can be used to inhibit cell proliferation.
Library Information
Targets:
BCL family; PARP family; Caspase family; MAPK family
Receptors:
p-Akt; Bcl-2 Family; P-gp (P-glycoprotein); p38 MAPK; PARP-1; Caspase-9; Caspase-3
Pathways:
DNA damage/DNA repair; Apoptosis; Autophagy; Membrane transporter/Ion channel; Cytoskeletal signaling; PI3K/Akt/mTOR signaling; Neuronal signaling; MAPK; Chromatin/Epigenetic; Proteases/Proteasome
Plate Number:
AOCL-7
Plate Location:
c9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 48.49 mM
